The United States is preparing to impose a 100% tariff on pharmaceuticals—reported by the Financial Times of the United Kingdom.

2026-04-02 03:24:53

Abstract generation in progress

Investing.com- According to a report by the British Financial Times on Wednesday citing people familiar with the matter, the Trump administration is preparing to impose 100% tariffs on certain drugs.

The Financial Times said these tariffs would be announced as early as Thursday, and would apply to companies that have not reached an agreement with the White House.

Subscribe to InvestingPro for more breaking news on Trump and U.S. policy

These tariffs would fulfill the threat Trump made at the end of last year. At the time, he threatened to impose tariffs of up to 100% on the import of brand-name drugs and patent drugs unless their manufacturers promised to build plants in the United States.

The Financial Times reported that the tariffs would also set a ceiling based on the import levels from countries that have reached agreements with the White House.

The move is part of a broader agenda by Trump to encourage greater investment and manufacturing in the United States. Pfizer, AstraZeneca, and Novo Nordisk are among the companies that have signed agreements with the White House.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.